Elin Borgen

Elin Borgen

UNVERIFIED PROFILE

Are you Elin Borgen?   Register this Author

Register author
Elin Borgen

Elin Borgen

Publications by authors named "Elin Borgen"

Are you Elin Borgen?   Register this Author

49Publications

1274Reads

36Profile Views

Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients.

J Proteome Res 2019 Oct 16;18(10):3649-3660. Epub 2019 Sep 16.

Department of Oncology , Oslo University Hospital , 0424 Oslo , Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.9b00316DOI Listing
October 2019

Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.

Breast Cancer Res Treat 2017 02 5;162(1):127-137. Epub 2017 Jan 5.

Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, PO Box 4953, 0424, Nydalen, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4096-1DOI Listing
February 2017

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

PLoS One 2015 13;10(10):e0139965. Epub 2015 Oct 13.

Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Radiumhospitalet-Oslo University Hospital, 0424 Oslo, Norway.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139965PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603798PMC
June 2016

NUT expression in primary lung tumours.

Diagn Pathol 2015 Sep 5;10:156. Epub 2015 Sep 5.

Department of Oncology, Oslo University Hospital, Radiumhospitalet 0310, Oslo, Norway.

View Article

Download full-text PDF

Source
http://www.diagnosticpathology.org/content/10/1/156
Publisher Site
http://dx.doi.org/10.1186/s13000-015-0395-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560868PMC
September 2015

Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival.

Ann Surg 2015 Jan;261(1):164-71

Departments of *Gastrointestinal Surgery †Biostatistics and Epidemiology ‡Pathology §Oncology, Oslo University Hospital, Oslo, Norway ¶Department of Gastrointestinal Surgery, Vestfold Hospital Trust, Tønsberg, Norway ∥Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000000580DOI Listing
January 2015

Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.

J Magn Reson Imaging 2014 Dec 27;40(6):1382-91. Epub 2014 Jan 27.

Department of Radiation Biology Institute of Cancer Research, Oslo University Hospital, Norway; Faculty of Medicine, University of Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.24502DOI Listing
December 2014

Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.

J Clin Oncol 2014 Dec 3;32(34):3848-57. Epub 2014 Nov 3.

Bjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk, Gro Wiedswang, Hilde H. Sommer, Anna Barbro Sætersdal, Maria Christine Rypdal, Cecilie Bendigtsen Schirmer, Erik Andreas Wist, and Elin Borgen, Oslo University Hospital; Bjørn Naume, Erik Andreas Wist, and Elin Borgen, K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo; Kjetil Weyde, Sykehuset Innlandet Trust, Gjøvik; Terje Risberg, University Hospital of Northern Norway and University of Tromsø, Tromsø; Christian Kersten, Sørlandet Hospital Trust, Kristiansand; Ingvil Mjaaland, Stavanger University Hospital, Stavanger; and Lise Vindi, Ålesund Hospital, Ålesund, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.9327DOI Listing
December 2014

Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital.

Res Rep Urol 2014 27;6:121-6. Epub 2014 Sep 27.

Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Radiumhospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/RRU.S68477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199652PMC
October 2014

Next-generation sequencing of disseminated tumor cells.

Front Oncol 2013 31;3:320. Epub 2013 Dec 31.

Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet , Oslo , Norway ; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo , Norway ; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital , Lørenskog , Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876274PMC
January 2014

Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.

Acta Oncol 2013 Jan 30;52(1):91-101. Epub 2012 Aug 30.

Department of Oncology, Division of Surgery and Cancer Medicine, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2012.713508DOI Listing
January 2013

Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.

Histol Histopathol 2012 10;27(10):1315-25

Department of Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-27.1315DOI Listing
October 2012

Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.

Breast Cancer Res Treat 2011 Feb 7;125(3):729-38. Epub 2010 May 7.

Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0911-2DOI Listing
February 2011

Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.

Histol Histopathol 2009 08;24(8):1049-59

Division of Pathology, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Faculty Division The Norwegian Radium Hospital, Medical Faculty University of Oslo, Montebello, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-24.1049DOI Listing
August 2009

Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.

Clin Cancer Res 2008 Apr;14(8):2341-50

Pathology Laboratories, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Montebello, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-4214DOI Listing
April 2008

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.

Int J Cancer 2006 Apr;118(8):2013-9

Department of Surgery, Ullevål University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21576DOI Listing
April 2006

Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.

Int J Surg Pathol 2004 Oct;12(4):311-8

Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Kristiansand, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/106689690401200404DOI Listing
October 2004